Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2026-05-03 @ 4:35 PM
Study NCT ID:
NCT02404350
Status:
COMPLETED
Last Update Posted:
2020-04-20
First Post:
2015-03-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis
Sponsor:
Organization: